Mélanie DALIGAULT

Doctorante – Rouen

6 documents

Hortense Petat, Alice Moisan, Chloé Dubus, Mathilde Chabut, Mélanie Daligault, et al.. Shifting Viral Landscapes: The Impact of Respiratory Syncytial Virus Immunization in Infant Bronchiolitis During 2024–2025 Epidemic Season in France. Journal of Medical Virology, 2025, 97 (8), ⟨10.1002/jmv.70515⟩. ⟨hal-05307897⟩
Thomas Jouve, Mélanie Daligault, Johan Noble, Florian Terrec, Farida Imerzoukene, et al.. Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study. Journal of Clinical Medicine, 2023, 12 (2), pp.424. ⟨10.3390/jcm12020424⟩. ⟨inserm-05007577⟩
Thomas Jouve, Caroline Laheurte, Johan Noble, Jules Weinhard, Mélanie Daligault, et al.. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. American Journal of Transplantation, 2022, 22 (1), pp.71-84. ⟨10.1111/ajt.16709⟩. ⟨inserm-05005378⟩
Johan Noble, Antoine Metzger, Hamza Naciri Bennani, Melanie Daligault, Dominique Masson, et al.. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation. Journal of Clinical Medicine, 2021, 10 (6), pp.1316. ⟨10.3390/jcm10061316⟩. ⟨hal-04997119⟩

Bertille Deseille, Jean-Philippe Leroy, André Gillibert, Hortense Petat, Véronique Lemée, et al.. Can we see early effects of nirsevimab in Normandy?. 42nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), May 2024, Copenhagen, Denmark. ⟨hal-05046463⟩

Bertille Deseille, Jean-Philippe Leroy, Franklin Ducatez, André Gillibert, Hortense Petat, et al.. Utilisation de données cliniques issues de l'Entrepôt de Données de Santé Normand (EDSaN) pour la surveillance active des bronchiolites après le déploiement du Nirsevimab en Normandie. Congrès de la Société Française de Pédiatrie, May 2024, Nantes, France. ⟨hal-05046477⟩